This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Allinky Biopharma, Consejo Superior De Investigaciones Cientificas. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Barcelona, ES (2015)
- Madrid, ES (2022)
Company Filing History:
Years Active: 2015-2022
Title: Esther Carrasco Romero: Innovator in Medicinal Chemistry
Introduction
Esther Carrasco Romero is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of novel compounds.
Latest Patents
Esther holds 2 patents that showcase her expertise in creating compounds with potential therapeutic applications. Her latest patents include:
1. **Tetrahydroisoquinoline Compounds** - This invention relates to a novel class of tetrahydroisoquinoline compounds of formula I and to compositions comprising the same. The compounds and compositions can be used as medicaments in the treatment of cancer.
2. **Chromene Derivatives** - This patent involves derivatives of chromene of formula I, where the meanings for the various substituents are as indicated in the description. These compounds are useful as inhibitors of TCR-Nck interaction in T lymphocytes.
Career Highlights
Esther has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and Allinky Biopharma. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Esther has collaborated with notable colleagues, including Irene Azahara Arellano Rojo and Balbino Jose Alarcon Sanchez. These partnerships have enriched her research endeavors and fostered innovation in her field.
Conclusion
Esther Carrasco Romero is a trailblazer in medicinal chemistry, with a focus on developing compounds that hold promise for cancer treatment and immune response modulation. Her contributions continue to impact the scientific community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile